Free Trial

Eterna Therapeutics (ERNA) SEC Filings & 10K Form

Eterna Therapeutics logo
$0.23 0.00 (-0.70%)
Closing price 04:00 PM Eastern
Extended Trading
$0.22 0.00 (-1.93%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Eterna Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2025
8:13 PM
Ernexa Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
HALPERN JOHN D (Filed by)
Form SCHEDULE 13G/A
05/15/2025
3:42 PM
Ernexa Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
Konar Shameek (Filed by)
Form SCHEDULE 13G
05/14/2025
7:39 PM
Ernexa Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
IAF, LLC (Filed by)
Form SCHEDULE 13G/A
05/14/2025
1:14 PM
Ernexa Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Ernexa Therapeutics Inc. (Subject)
Freebird Partners LP (Filed by)
Form SCHEDULE 13G/A
05/07/2025
10:48 AM
Cherington Charles (Reporting)
Ernexa Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Ernexa Therapeutics Inc. (Issuer)
Form 4/A
04/29/2025
11:15 PM
Ernexa Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
Form EFFECT
04/16/2025
3:30 PM
Ernexa Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/14/2025
4:05 PM
Ernexa Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Ernexa Therapeutics Inc. (Filer)
Form ARS
04/04/2025
9:54 AM
Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
9:55 AM
Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Form SCHEDULE 13D/A
04/03/2025
4:17 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form PRE 14A
04/03/2025
7:55 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
6:30 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:20 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2025
4:55 PM
Cherington Charles (Filed by)
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Form SCHEDULE 13D/A
02/14/2025
8:30 PM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Singer Nicholas Jason (Filed by)
Form SCHEDULE 13G/A
02/14/2025
7:36 PM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
HALPERN JOHN D (Filed by)
Form SCHEDULE 13G/A
02/12/2025
4:54 PM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
IAF, LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
6:00 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Luther Sanjeev (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM
Cicala Peter (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM
Bristol James Arthur (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:00 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Wexler William A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:31 PM
Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics (Subject)
Eterna Therapeutics Inc. (Subject)
Freebird Partners LP (Filed by)
Form SCHEDULE 13G/A
01/14/2025
4:00 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Ratner Elena (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2025
4:01 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Ratner Elena (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 424B3
11/18/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 424B3
11/18/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 424B3
11/17/2024
11:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form EFFECT
11/14/2024
5:45 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
11/14/2024
5:45 AM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
11/05/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/05/2024
11:42 AM
Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form ARS
09/27/2024
3:47 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form PRE 14A
09/27/2024
3:15 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:36 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump Predicts Dollar Downfall (Ad)

READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... This is what President Trump said: "Our currency is crashing and will soon no longer be the world standard, which will be our greatest defeat, frankly, in 200 years." Why Would He Say This?

Claim your free, no-strings-attached 2025 Ultimate Guide to Gold IRAs right now.
09/23/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:00 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:30 PM
Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics (Filer)
Eterna Therapeutics Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/25/2024
3:32 PM
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics (Issuer)
Eterna Therapeutics Inc. (Issuer)
Gurrola Sandra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ERNA) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners